Strategic Blueprint, LLC Abb Vie Inc. Transaction History

Strategic Blueprint, LLC

$1.49 Billion
Q3 2024

A detailed history of Strategic Blueprint, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Strategic Blueprint, LLC holds 10,104 shares of ABBV stock, worth $1.83 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

10,104

Previous 11,336 10.87%

Holding current value

$1.83 Million

Previous $1.94 Million 2.62%

% of portfolio

0.13%

Previous 0.14%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$163.84 - $199.33 $201,850 - $245,574	-1,232 Reduced 10.87%	10,104 $2 Million
Q2 2024 Jul 26, 2024	BUY	$154.79 - $180.76 $30,958 - $36,152	200 Added 1.8%	11,336 $1.94 Million
Q1 2024 Apr 23, 2024	BUY	$159.82 - $182.1 $109,636 - $124,920	686 Added 6.56%	11,136 $2.03 Million
Q4 2023 Jan 25, 2024	SELL	$137.6 - $154.97 $117,785 - $132,654	-856 Reduced 7.57%	10,450 $1.62 Million
Q3 2023 Oct 18, 2023	BUY	$133.59 - $154.65 $38,206 - $44,229	286 Added 2.6%	11,306 $1.69 Million
Q2 2023 Oct 18, 2023	BUY	$132.51 - $164.9 $9,540 - $11,872	72 Added 0.66%	11,020 $1.48 Million
Q1 2023 Apr 28, 2023	BUY	$144.61 - $166.54 $117,423 - $135,230	812 Added 8.01%	10,948 $1.74 Million
Q4 2022 Jan 26, 2023	BUY	$138.31 - $165.87 $24,480 - $29,358	177 Added 1.78%	10,136 $0
Q3 2022 Nov 08, 2022	BUY	$134.21 - $153.93 $108,307 - $124,221	807 Added 8.82%	9,959 $1.34 Million
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $28,487 - $36,216	207 Added 2.31%	9,152 $1.4 Million
Q1 2022 Aug 12, 2022	SELL	$131.98 - $163.75 $107,827 - $133,783	-817 Reduced 8.37%	8,945 $1.45 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $145,245 - $183,777	1,352 Added 16.08%	9,762 $1.32 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $110,336 - $125,248	-1,037 Reduced 10.98%	8,410 $907,000
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $130,355 - $145,223	1,239 Added 15.1%	9,447 $1.06 Million
Q1 2021 May 10, 2021	BUY	$102.3 - $112.62 $80,203 - $88,294	784 Added 10.56%	8,208 $888,000
Q4 2020 Jan 26, 2021	BUY	$80.49 - $108.67 $44,028 - $59,442	547 Added 7.95%	7,424 $795,000
Q3 2020 Oct 27, 2020	BUY	$85.91 - $100.83 $590,803 - $693,407	6,877 New	6,877 $602,000
Q4 2019 Jan 10, 2020	SELL	$72.13 - $90.25 $125,145 - $156,583	-1,735 Closed	0 $0
Q3 2019 Oct 16, 2019	BUY	$62.98 - $75.72 $109,270 - $131,374	1,735 New	1,735 $131,000
Q1 2019 Apr 10, 2019	SELL	$77.14 - $90.79 $868,210 - $1.02 Million	-11,255 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $876,201 - $1.08 Million	11,255 New	11,255 $1.04 Million

Others Institutions Holding ABBV

# of Institutions

3,854

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $320B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Blueprint, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Blueprint, LLC with notifications on news.

Account

Strategic Blueprint, LLC Abb Vie Inc. Transaction History